Alyeska Investment Group
NVNO

Alyeska Investment Group’s enVVeno Medical NVNO Stock Holding History

Alyeska Investment Group’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,977
Closed -$632K – 618
2024
Q4 		$632K Sell
5,977
-6,166
-51% -$689K ﹤0.01% 511
2024
Q3 		$1.43M Buy
+12,143
New +$2.23M 0.01% 441

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Alyeska Investment Group's NVNO Position: Q1 2025 in Review

Alyeska Investment Group sold out of enVVeno Medical (NVNO) in Q1 2025, closing a stake of 5,977 shares — an estimated $632K sold.

Alyeska Investment Group first reported a position in NVNO in Q3 2024 and held it in 2 quarters. The position peaked at $1.43M in Q3 2024. 30 funds tracked by Wall St. Rank hold NVNO as of Q1 2025.

  • Alyeska Investment Group reported no remaining enVVeno Medical position as of Q1 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 5,977 enVVeno Medical shares in Q1 2025, an estimated $632K.
  • Alyeska Investment Group first reported a position in enVVeno Medical in Q3 2024 and held it in 2 quarters.
  • Alyeska Investment Group's enVVeno Medical position peaked at $1.43M in Q3 2024.
  • 30 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2025.

Based on Alyeska Investment Group's 13F filing for Q1 2025, filed 15 May 2025.